Hospital visiting guidelines updated 20 July 2022: Hospital visitors must wear a surgical/medical paper mask. Fabric face coverings are no longer acceptable. See our COVID-19 pages for detailed information about hospital visiting guidelines, COVID-19 tests and care in the community advice. See www.vaccinatecanterburywestcoast.nz for information about vaccinations.
We are at ORANGE according to the NZ COVID-19 Protection Framework
Last updated:
9th April 2022
Kia whakahaumaru te whānau, me ngā iwi katoa – this is to keep everybody safe:
By sticking to the rules above, you help keep our patients, staff, other visitors and yourself safe. We thank you in advance for your patience and understanding as our staff work hard to protect and care for some of the most vulnerable in our community.
Exceptions to the ‘one visitor’ policy
Visiting patients with COVID-19
You must NOT visit the hospital if you
Exceptions for people with disabilities
An exception will be made for people with disabilities who are in hospital or have to attend an outpatient appointment – where they need a support person to access health services. For example, a sign language interpreter, support person for someone with a learning disability, or someone to assist with mobility. The support person is in addition to the one permitted visitor.
Everyone visiting our facilities must wear a mask, no exceptions
While we appreciate that some people have legitimate reasons for being exempt from wearing a mask and may even have an official card to confirm this, people who cannot or will not wear a mask cannot visit someone in hospital or attend hospital, other than to access healthcare. This is another measure to minimise the risk to vulnerable patients.
Patients and visitors should also read the additional more detailed visiting guidelines for each specific hospital.
More COVID-19 information
Mutations in the LDLR gene (or APOB/APOE/PCSK9) may cause the condition called familial hypercholesterolaemia (FH). When a disease-causing LDLR mutation is identified in a patient (the proband), members of their family can be subsequently screened to determine if they also carry the familial mutation.
Genetics - Molecular Pathology
MOLP
FH
Hyperlipidemia
4 weeks
4568
4.0
1
1.0
0.5
This genetic test needs nucleated cells. Please don’t centrifuge or freeze the EDTA blood tube.
If storing blood tube prior to delivery please refrigerate at 4 degrees (transport still at ambient temperature).
Ambient (8 - 24 degrees Celsius)
This genetic test needs nucleated cells. Please don’t centrifuge or freeze the EDTA blood tube.
If storing blood tube prior to delivery please refrigerate at 4 degrees (transport still at ambient temperature).
LDLR mutations show a standard autosomal pattern of inheritance. Providing the DNA sequence quality is acceptable this test is conclusive in determining the carrier status of the patient.
The LDLR (or APOB/APOE/PCSK9) exon in which the proband’s mutation is located is amplified by PCR and sequenced by bi-directional Sanger nucleotide sequencing.
$264.00 (Exclusive of GST)
4593
Uncertainty of Measurement:
Automated bidirectional DNA sequencing has an analytical sensitivity and specificity of >99%. Note that the lower limit of variant detection of sequencing analysis is ~10%, this is important to consider in the case of mosaicism, mitochondrial, and somatic variation that is not expected to be present at 50% or 100%. This analysis will not detect variants located within intronic regions, except at the intron-exon boundaries.